Kristina G. Laut1,2*, MPH; Chris P. Gale3,4, MD, PhD; Alma B. Pedersen2, MD, PhD; Keith A. A. Fox5, MD, PhD; Timothy L. Lash2,6, DSc, MPH; Steen D. Kristensen1, MD, DMSc
1. Department of Cardiology, Aarhus University Hospital, Skejby, Denmark; 2. Department of Clinical Epidemiology, Aarhus University Hospital, Denmark; 3. Centre for Epidemiology and Biostatistics, University of Leeds, Leeds, United King
Aims: Large inequalities in the use of primary percutaneous interventions (PPCI) for ST-elevation myocardial infarction (STEMI) are evident. In